Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “GALEN”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 199 records · Page 11Linked to original sources

Thrombosed vein of Galen aneurysm.

The authors report a case of thrombosed vein of Galen aneurysm in a 4.5-year-old girl with craniofacial dysostosis (Crouzon's disease). Six previously reported cases appear in the literature. The initial presentation is often associated with the symptoms and signs of hydrocephalus. Computed tomography shows an enhancing mass in the region of the posterior 3rd ventricle with the characteristic "target sign." Arteriography of all aspects of both the anterior and the posterior cerebral circulation is essential. Surgical results in cases of vein of Galen aneurysm have generally been poor, but recent reports of successful operative intervention to treat the thrombosed variety promise satisfactory treatment.

Calcinosis↗

[Medical demonstrations in Rome at the time of Galen].

Because of his autobiographical recollections, Galen is an exceptional witness of physicians' public activities in Rome at the time of the Second Sophistic. His accounts of his anatomical demonstrations and of his public instruction vividly demonstrate the place of rhetoric and of improvisation in these performances. It likewise illustrates his contacts with the audience and his encounters with the sophists. With respect to this activity, Galen himself had contradictory feelings. Although he gave it up quite soon, he remained profoundly marked by it.

Complementary Therapies↗

Science as text, science as history: Galen on metaphor.

This paper addresses three related questions: (1) What is Galen's theory of metaphor, and why is metaphor so important to him? (2) What is the place of metaphor in Galen's general theory of the language of science? (3) What is the relation of his theory of metaphor to his views on the historical dimension of language and to the historicity of science?

Greece, Ancient↗

The embarrassment of imperfection: Galen's assessment of Hippocrates' linguistic merits.

In antiquity the 'higher' study of medicine shared with many other disciplines a pronounced philological character. Galen both exploited this 'philological paradigm' and underwent its influence. He exploited it in that it enabled him to invest the Corpus Hippocraticum with a dignity comparable to that of Homer only. But his philological instrumentarium, originally designed for the study of literary texts, also forced him to pose and answer certain questions that shed no light whatsoever on the informational content of Hippocrates' writings, questions about Hippocrates' language and style. Galen disentangles himself from the ensuing embarrassment by claiming that Hippocrates' style was ideal for the specific didactic genre he was involved in. This special style necessitates a reassessment of customary grammatical and rhetorical values: correctness recedes into the background, clarity and brevity become the predominant virtues of style.

Greece, Ancient↗

Aneurysm of the vein of Galen presenting with proptosis.

A case of proptosis, arterio-venous malformation and aneurysm of the Vein of Galen in a 12 year old schoolboy is presented. This is in addition to the literature of the rare aneurysm involving the Great Vein of Galen. This is the first time this syndrome will be described in association with ophthalmic presentation. It is however remarkable that with such a huge sized aneurysm and A-V malformation, the patient did not have any other neurological deficit except visual field loss. Perhaps the previous series had undetectable visual field loss which was missed as patients might not have complained of visual symptoms.

Aneurysm↗

Vein of Galen aneurysms: a review and current perspective.

Our approach to treating a patient with a vein of Galen aneurysm is, of course, influenced greatly by the age of the patient, the clinical symptoms, and the angiographic architecture of the malformation. Therapeutic options are primarily based on whether a true AVM is present or if the malformation represents an arteriovenous fistula involving the vein of Galen. Arterial endovascular approaches, microneurosurgery, and/or radiosurgery are preferred for management of the former; the transvenous endovascular approach has become the cornerstone of treatment in the latter. The most critical group, however, is the neonates in extreme cardiovascular distress. In this case our therapeutic intervention is initially endovascular from the venous side, either transfemoral or transtorcular. The immediate goal is to increase resistance to right ventricular output. Advantages of this approach over a transarterial approach include a shorter anesthesia time, minimal fluid and/or contrast administration, and creation of a wire "basket" or "bird's nest" on the venous side that helps prevent emboli that may be deposited on the arterial side in subsequent embolizations from passing through the malformation. The transvenous approach can be easily repeated multiple times and may be supplemented by transarterial embolizations. Endovascular coils have been the mainstay for such venous embolizations. The end point of treatment is not complete occlusion of the fistula but improvement in cardiac function. Often, more than one stage is required to reach our goal. The results in recent years have been encouraging and are to a large degree attributable to the advances in endovascular approaches. With future improved tools for diagnosis and treatment, perhaps the prognosis for this difficult malady also will continue to improve.

Arteriovenous Fistula↗

Vein of Galen fistulas.

The vein of Galen malformations continue to be challenging lesions for the neurosurgeon. Evolving therapies, including transvenous and transarterial embolotherapies, have dramatically changed our approach to these lesions over the past 5 years. The neurosurgeon remains the physician in charge of the care of these individuals. In neonates suffering from severe progressive cardiac failure, about a 50% survival rate can be expected. Those patients demonstrating significant injury to the central nervous system prior to therapy should probably be excluded from the aggressive treatment category. Low morbidity and mortality can be expected in the infant and older childhood group of patients harboring vein of Galen malformations treated interventionally. The tendency today is toward a combined transvenous transarterial approach to these lesions, no matter which clinical category is treated. Aggressive therapy is indicated in the control of hydrocephalus and seizures before, during, and after treatment. The overall philosophy, especially in the transvenous approach to these lesions, remains the careful and repeated embolization of these lesions in a staged fashion to encourage a graded thrombosis in an attempt to minimize the risk of hemorrhage and injury to the central nervous system. The overall prognosis is difficult to predict at this time, but it would appear to be better than with standard surgical treatment of these lesions. These therapies are evolving, and further improvements in the techniques and outcome are anticipated.

Cerebral Veins↗

[Radical removal of a totally thrombosed vein of Galen aneurysm preoperatively diagnosed as a pineal neoplasm].

A case of an eight-year-old with signs of a pineal region tumor who underwent radical removal of a totally thrombosed vein of Galen aneurysm through the infratentorial supracerebellar approach. Pathophysiology of vein of Galen malformations including variety of clinical course, angiographic appearance and prognosis was described. Predisposition to spontaneous thrombosis in that type of malformations indicates necessity of taking into account such cases in the differential diagnosis of pineal region tumors.

Brain↗

Goals for concept representation in the GALEN project.

The GALEN project aims to develop language independent concept representation systems as the foundations for the next generation of multilingual coding systems. Traditional coding schemes have reached the limits of what can be maintained and managed, and a shift to formal compositional systems is now essential. GALEN is developing one such scheme and an associated concept model, together with criteria for their evaluation. It should provide the flexibility required to cope with the diversity amongst medical applications, whilst ensuring the coherence necessary for integration and re-use of terminologies.

Humans↗

[Comparative effectiveness and tolerance study of a new galenic etomidate formula].

OBJECTIVE AND STUDY DESIGN: One of the major disadvantages of etomidate is the high frequency of pain on injection. A new galenic formulation based on a lipid emulsion for etomidate (Etomidat-Lipuro) was compared with the commercial standard (etomidate in propylene glycol, Hypnomidate) in a prospective, randomised, double-blind clinical evaluation in 232 patients undergoing elective surgery in general anaesthesia. The patients were premedicated with flunitrazepam 2 hours before the investigation. Two intravenous cannulas were inserted in veins of forearm or back of the hand. One cannula was only used for the application of etomidate and removed immediately after injection. General anaesthesia was induced with 0.3 mg/kg etomidate at an injection rate of 20 mg/30 s. If the patient did not complain of pain or other sensations during injection spontaneously, he was questioned for 15 s after beginning of injection. The arm used for application of etomidate was kept free of any manipulation during the operation and the following five postoperative days. RESULTS: There were marked differences between the two etomidate preparations concerning venous irritation. About 20% of the patients receiving the hypnotic in propylene glycol complained spontaneously of pain on injection, whereas none with the lipid emulsion. No difference was found in the incidence of myoclonic movements. The time interval between the beginning of injection and loss of eyelid closure reflex was about 50 s and not different for the two galenic formulations. Blood pressure during and after induction of anaesthesia did not differ. The heart rate in the group of patients with etomidate in lipid emulsion was slightly increased before and immediately after intubation compared to the propylene glycol group. 4% of the patients in the propylene glycol group suffered from postoperative venous complications as reddening, swelling, induration or pain. These complications could not be seen in the lipid emulsion group.

Adult↗

Constructing clinical applications: the GALEN approach.

A common problem for developers of clinical applications is coping with the diversity of medical language. Medical language as it is used all over the world varies widely, while the referents for these words stay essentially the same. Software developers must reconcile this diversity with the practical necessity of producing applications that are usable in a variety of hospitals, while ensuring that information can be shared between applications. Existing approaches center around coding and classification schemes, but these approaches must be supplemented by a range of sophisticated terminological services in order for the language barriers to be overcome. To address this, the GALEN project is developing an application called the Terminology Server to provide such a range of terminological services (e.g., conceptual and multilingual services). The software is built upon a re-usable core model of medical terminology. This paper reports on the development of a clinical application called the SCUI (Structured Clinical User Interface) which draws on these GALEN technologies and illustrates an innovative approach to the construction of future clinical applications. The SCUI was specifically developed and tested in the context of infectious diseases to satisfy the demands made by the medical intensive care unit on the Geneva Hospital's microbiology laboratory.

Clinical Laboratory Information Systems↗

Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration.

Oxerutins (O-(beta-hydroxyethyl)-rutosides, HR, Venoruton) are available in different releasing galenical formulations for the treatment of chronic venous insufficiency (CVI). In order to investigate the biopharmaceutical relevance of the releasing properties of the galenical forms the therapeutic efficacy between the commercially available forms was investigated (500 mg sustained release film tablets, 300 mg sustained release film tablets, 300 mg normally releasing capsules) in comparison to an aqueous solution and placebo. In total 100 female patients with CVI grade II participated. The study was carried out following a randomized, placebo controlled design with parallel treatment groups. Following a two-week run-in phase patients were treated for 12 weeks with different posologies of HR (2 x 1/d 500 mg, 3 x 1/d 300 mg, 1 x 1000 mg/d as aqueous solution). Main criterion was the reduction of leg volume following 12 weeks treatment. Subjective criteria were descriptively evaluated. All four HR treatments were significantly superior to placebo (p < 0.0008). The different posologies had no influence on the efficacy. The therapeutic efficacy is independent of the in vitro rate of release. The available forms are regarded as bioequivalent.

Aged↗

Comparison of calcium retention measured using a radionuclide method after administration of 1000 mg elemental calcium in two different galenic forms, in one or two doses.

A randomized, open, crossover, two-phase study was conducted to compare body retention of calcium measured using a radionuclide method after acute oral administration of 1 000 mg elemental calcium in two different galenic forms, in one or two doses. In the first phase of the study, which included 14 volunteers, the two treatments were one dissolve-in-the-mouth tablet of calcium carbonate in the morning and one in the evening (Orocal 500 mg) (treatment A1) and one effervescent tablet calcium carbonate (Cacit 1000) (treatment B). In the second phase in 8 volunteers, treatment A1 (Orocal 500 mg) was compared to two tablets of the same preparation in a single dose (Orocal 500 mg) (treatment A2). Each treatment contained a tracing dose of 47Ca. Body retention, expressed as the percentage of the total dose and measured seven and 14 days after each treatment, was significantly greater with Orocal 500 mg than with Cacit 1000 (24.21 +/- 3.38 versus 11.96 +/- 2.50 on day 7; 20.22 +/- 3.26 versus 9.67 +/- 2.56 on day 14; p < 0.001). Retention after administration of Orocal 500 mg was slightly better with two doses than with one dose (24.66 +/- 3.44 versus 21.32 +/- 7.63 on day 7; 20.19 +/- 3.28 versus 17.29 +/- 6.63 on day 14). Twenty-five per cent of the difference in calcium retention between treatments A1 (Orocal 500 mg) and B (Cacit 1000) was ascribable to the dosing schedule difference and 75% to the differences in galenic characteristics.

Administration, Oral↗

[Arteriovenous malformations associated with aneurysms of the vein of Galen].

The aneurysms of the vein of Galen may be defined as a midline arteriovenous fistula with aneurysmal dilatation of the median venous sac. From the literature and author's experiences a survey of embryology, pathophysiology as well as contemporary state of diagnosis and therapy of vein of Galen malformation is presented.

Cerebral Veins↗

Arteriovenous malformations of vein of Galen: microsurgical treatment.

The surgical technic used at the neurosurgical clinic in Zürich in eradicating arteriovenous malformations of the vein of Galen is described. It is based on experience with nine cases. The surgical approach is made posteriorly. The right occipital lobe is retracted laterally from the falx cerebri. The multiple feeding vessels demonstrated in the angiogram are occluded; first, on the right side, then the left, and finally beneath the malformation. The draining vein of Galen is not occluded or removed. The use of the operating microscope is essential.

Adolescent↗

[Fatal subarachnoid hemorrhage originating from the region of the great vein of Galen following a "fight" (author's transl)].

Report of the case of a 12-year-old boy who had died due to a massive basal subarachnoid hemorrhage after moderate fight with a class mate. Findings at autopsy and by microscopic examination indicated that a lesion in the system of the great vein of Galen and the internal cerebral veins might have been the source of the bleeding. The nature of an underlying pre-existing vascular change favoring a rupture is discussed on the basis of the clinical history and the pathoanatomic findings.

Brain↗

Hydrodynamics in vein of Galen malformations.

Forty-three patients with vein of Galen aneurysmal malformations (VGAM) referred to us for endovascular treatment between 1985 and 1990 and 335 additional cases published in the literature were reviewed with particular attention to the presence of ventricular enlargement and outcome after shunting. Hydrocephalus was the second most frequent symptom (46.8%); it is more frequent in infants (73%) than in children, adults (30%) or neonates (15%). Of the patients reported in the literature, 17.9% had undergone shunting. Within the shunted population there was an overall morbidity of 41% and a mortality of 10% (especially in the infant group). In our series 17 patients (39.5%) were shunted and a significant difference in the clinical outcome was noted between the shunted and the nonshunted group. Of the nonshunted patients, 66.6% were free of any neurological deficit or mental retardation and fewer than 5% presented with significant mental retardation. On the other hand, only 33.3% of the shunted patients had a favorable outcome and more than 15% developed significant mental retardation. Among the various causes of hydrocephalus in patients with VGAMs, such as obstruction of the aqueduct, subarachnoid hemorrhage, or ex vacuo hydrocephalus, high venous pressure may be of particular importance. In this article a physiopathological interpretation of the hydrodynamics in VGAMs is developed and a speculative explanation for CSF disorders related to ventricular shunting proposed. Treatment of hydrocephalus in VGAMs can be achieved through obliteration of the malformation or at least diminishing the venous pressure; surgical ventricular shunting does not have to be the first treatment of hydrodynamic disorders associated with VGAMs, especially in infants.

Brain Damage, Chronic↗

Reversible tonsillar prolapse in vein of Galen aneurysmal malformations: report of eight cases and pathophysiological hypothesis.

We report eight cases of vein of Galen aneurysmal malformation (VGAM) associated with a "Chiari type I malformation." In four cases magnetic resonance imaging (MRI) or computed tomography performed in the neonatal period did not demonstrate the posterior fossa anomaly, which appeared on later scans. In the other cases the MRI was performed in infancy and the anomaly was already present. We compared the venous phases of the posterior fossa angiograms and the MRI in these patients. In all eight cases, the angiograms showed a reflux in the cerebellar veins, via the petrous vein, associated with a uni- or bilateral stenosis or thrombosis of the distal posterior dural sinuses. Furthermore, in two cases the posterior fossa returned to normal on MRI following endovascular treatment, while in three cases the herniation of the cerebellar tonsils decreased after the embolization. Tonsillar prolapse becomes irreversible when the venous outlet is incapable of taking the flow even when the VGAM has been treated adequately. In eight additional cases of VGAM for which MRI and angiogram studies were available and in which stenosis or thrombosis of posterior dural sinuses was present without tonsillar prolapse, no reflux into the cerebellar veins was shown. We suggest that the posterior fossa hydrovenous congestion is a result of inadequate venous drainage and that the tonsillar descent is reversible if adequate venous drainage is reconstituted following therapeutic embolization of the fistula. Tonsillar prolapse is not a consequence of mass or raised intraventricular pressure. Our observation suggests that in some other conditions, the "Chiari I malformations" may be secondary to early hydrovenous dysfunction of the posterior fossa.

Arteriovenous Shunt, Surgical↗